Login Register Cart 0
Generic placeholder image

Current Chromatography

Editor-in-Chief

ISSN (Print): 2213-2406
ISSN (Online): 2213-2414

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Determination of Doxycycline and Rifampicin in Polymeric Nanoparticles

Author(s): Shilpa Dawre*

Volume 9, Issue 1, 2022

Published on: 13 July, 2022

Article ID: e070322201805 Pages: 9

DOI: 10.2174/2213240609666220307110010

Price: $65

Abstract

Background: The combination of doxycycline (DOXY) and rifampicin (RIF) is recommended as a treatment therapy for brucellosis by the World Health Organization.

Objective: The aim of the current study was to develop and validate the stability-indicating reversephase high-performance liquid chromatography (RP-HPLC) method for the analysis of a combination of doxycycline & rifampicin.

Methods: The RP-HPLC method was developed and validated to estimate the doxycycline and rifampicin combination as per ICH guidelines. The drug combination solution was exposed to different stress conditions: acidic, basic, photo-oxidation, and oxidation.

Results: The method was found linear in the range of 2 -10μg/mL for both the drugs with a retention time of 3.5 min for doxycycline and 6.5 min for rifampicin at lambda maximum of 350 nm. The RP-HPLC method was precise and accurate with %RSD < 2%. The intra-day and inter-day precisions were calculated and found within the acceptable range of 5%. Both drugs demonstrated good stability in the mobile phase after 6 hours. The LOD and LOQ of doxycycline and rifampicin were 100 ng/mL & 200ng/mL and 150ng/mL & 500ng/mL, respectively. The forced degradation of the combination of drug solutions was performed. The degraded drug peaks were well-resolved from the peaks of drugs. The percentage encapsulation efficiency of doxycycline and rifampicin in the nanoparticle system was assessed by utilizing the validated RP-HPLC method and found >60% (DOXY) and >70% (RIF).

Conclusion: The developed RP-HPLC method of DOXY-RIF combination was rapid, accurate, precise, and stability-indicating. The method can be appropriately applied todetecte drugs in the nanoparticulate system.

Keywords: Simultaneous method, doxycycline- rifampicin combination, reverse-phase high-performance liquid chromatography (RP-HPLC), validation, stability indicating RP-HPLC method, polymeric nanoparticles.

Graphical Abstract

[1]
Centers for disease control and prevention, National center for emerging and zoonotic infectious diseases (NCEZID), Division of high-consequence pathogens and pathology (DHCPP) 2021. Available from: http://www.cdc.gov/
[2]
Holmes, N.E.; Charles, P.G.P. Safety and efficacy review of doxycycline. Clin. Med. Ther., 2009, 1, 471-482.
[http://dx.doi.org/10.4137/CMT.S2035]
[3]
National center for biotechnology information. PubChem Compound Summary for CID 54671203, Doxycycline, 2021. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Doxycycline Accessed Accessed Jan. 12, 2021.
[4]
Kogawa, A.C.; Tomita, L.K.; Salgado, H. Development and validation of a stability-indicative turbidimetric assay to determine the potency of doxycycline hyclate in tablets. Int. J. Microbiol. Res., 2012, 24(8), 316-321.
[http://dx.doi.org/10.9735/0975-5276.4.8.316-321]
[5]
Skúlason, S.; Ingólfsson, E.; Kristmundsdóttir, T. Development of a simple HPLC method for separation of doxycycline and its degrada-tion products. J. Pharm. Biomed. Anal., 2003, 33(4), 667-672.
[http://dx.doi.org/10.1016/S0731-7085(03)00316-9] [PMID: 14623592]
[6]
Weng, Naidong Geelen, S.; Roets, E.; Hoogmartens, J. Assay and purity control of oxytetracycline and doxycycline by thin-layer chro-matography-a comparison with liquid chromatography. J. Pharm. Biomed. Anal., 1990, 8(8-12), 891-898.
[http://dx.doi.org/10.1016/0731-7085(90)80138-F] [PMID: 2100638]
[7]
Krishna, A.C.; Sathiyaraj, M.; Saravanan, R.S.; Chelladurai, R.; Vignesh, R. A novel and rapid method to determine doxycycline in human plasma by liquid chromatography tandem mass spectrometry. Indian J. Pharm. Sci., 2012, 74(6), 541-548.
[http://dx.doi.org/10.4103/0250-474X.110599] [PMID: 23798780]
[8]
Feng, X.; Ashley, J.; Zhou, T.; Sun, Y. Fluorometric determination of doxycycline based on the use of carbon quantum dots incorporated into a molecularly imprinted polymer. Mikrochim. Acta, 2018, 185(11), 500.
[http://dx.doi.org/10.1007/s00604-018-2999-8] [PMID: 30293175]
[9]
Eticha, T.; Kahsay, G.; Asefa, F.; Hailu, T.; Gebretsadik, H.; Gebretsadikan, T.; Thangabalan, B. Chemometric-assisted spectrophotometric method for the simultaneous determination of ciprofloxacin and doxycycline hyclate in pharmaceutical formulations. J. Anal. Methods Chem., 2018, 2018, 9538435.
[http://dx.doi.org/10.1155/2018/9538435] [PMID: 30662790]
[10]
National center for biotechnology information PubChem Compound Summary for CID 135398735, Rifampicin, 2021. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Rifampicin (Accessed Jan. 12, 2021).
[11]
National library of medicine (US), National center for biotechnology information; 2004-. PubChem Compound Summary for CID 135900090, Rifampin, 2004. Available from:https://pubchem. ncbi.nlm.nih.gov/compound/Rifampin
[12]
Solera, J.; Rodríguez-Zapata, M.; Geijo, P.; Largo, J.; Paulino, J.; Sáez, L.; Martínez-Alfaro, E.; Sánchez, L.; Sepulveda, M.A.; Ruiz-Ribó, M.D. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI group. Grupo de estudio de castilla-la mancha de enfermedades infecciosas. Antimicrob. Agents Chemother., 1995, 39(9), 2061-2067.
[http://dx.doi.org/10.1128/AAC.39.9.2061] [PMID: 8540716]
[13]
Dawre, S.; Devarajan, P.V.; Samad, A. Enhanced antibacterial activity of doxycycline and rifampicin combination loaded in nanoparticles against intracellular Brucella abortus. Curr. Drug Deliv., 2021. Online ahead of print
[http://dx.doi.org/10.2174/1567201818666210609164704] [PMID: 34151761]
[14]
Swamy, N.; Basavaiah, K.; Vamsikrishna, P. Stability-indicating HPLC determination of rifampicin in bulk drug and dosage form. Pharm. Chem. J., 2019, 53(6), 580-588.
[http://dx.doi.org/10.1007/s11094-019-02041-9]
[15]
Kumar, S.; Bouic, P.J.; Rosenkranz, B. A validated stable HPLC method for the simultaneous determination of rifampicin and 25- O -desacetyl rifampicin – evaluation of in vitro metabolism. Acta Chromatogr., 2019, 31(2), 92-98.
[http://dx.doi.org/10.1556/1326.2018.00361]
[16]
Shishoo, C.J.; Shah, S.A.; Rathod, I.S.; Savale, S.S.; Kotecha, J.S.; Shah, P.B. Stability of rifampicin in dissolution medium in presence of isoniazid. Int. J. Pharm., 1999, 190(1), 109-123.
[http://dx.doi.org/10.1016/S0378-5173(99)00286-0] [PMID: 10528103]
[17]
Hammam, E.; Beltagi, A.; Ghoneim, M. Voltammetric assay of rifampicin and isoniazid drugs, separately and combined in bulk, pharma-ceutical formulations and human serum at a carbon paste electrode. Microchem. J., 2004, 77(1), 53-62.
[http://dx.doi.org/10.1016/j.microc.2003.12.003]
[18]
Abate, G.; Aseffa, A.; Selassie, A.; Goshu, S.; Fekade, B.; WoldeMeskal, D.; Miörner, H. Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J. Clin. Microbiol., 2004, 42(2), 871-873.
[http://dx.doi.org/10.1128/JCM.42.2.871-873.2004] [PMID: 14766876]
[19]
Pourmoslemi, S.; Mirfakhraee, S.; Yaripour, S.; Mohammadi, A. Development and validation of a stability- Indicating RP-HPLC method for rapid determination of doxycycline in pharmaceutical bulk and dosage forms. Pharm. Sci., 2016, 22(2), 96-104.
[http://dx.doi.org/10.15171/PS.2016.16]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy